Table 1.
Laboratory Data of the Patient.
| Peripheral blood | |||
| White blood cells | 3,800 | /µL | |
| Hemoglobin | 9.2 | g/dL | |
| Platelets | 32×104 | /µL | |
| Blood analysis | |||
| Total protein | 7.3 | g/dL | |
| Albumin | 4.3 | g/dL | |
| Creatinine kinase | 55 | IU/L | |
| Blood urea nitrogen | 9 | mg/dL | |
| Creatinine | 0.58 | mg/dL | |
| Total bilirubin | 0.5 | mg/dL | |
| Aspartate aminotransferase | 15 | IU/L | |
| Alanine aminotransferase | 7 | IU/L | |
| Amylase | 85 | IU/L | |
| Lactate dehydrogenase | 128 | IU/L | |
| Alkaline phosphatase | 164 | IU/L | |
| γ-glutamyl transpeptidase | 12 | IU/L | |
| Triglyceride | 57 | mg/dL | |
| Total cholesterol | 206 | mg/dL | |
| High density lipoprotein | 77 | mg/dL | |
| Low density lipoprotein | 104 | mg/dL | |
| aPTT | 24.4 | s | |
| PT | 100.4 | % | |
| PT-INR | 1 | ||
| Immunology | |||
| Alpha-fetoprotein | 224 | ng/mL | |
| Alpha-fetoprotein-L3 | 51.1 | % | |
| PIVKA-II protein | 21 | mAU/mL | |
| Infection | |||
| HBsAg | Negative | ||
| HBsAb | Negative | ||
| HBcAb | Negative | ||
| HCV RNA | Negative | ||
| HCV antibody | Negative |
aPTT: activated partial thromboplastin time, HBcAb: hepatitis B core antibody, HBsAb: hepatitis B surface antibody, HBsAg: hepatitis B surface antigen, HCV: hepatitis C virus, INR: international normalized ratio, PT: prothrombin time